Source-grounded facts extracted from MOBIX LABS, INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
MOBIX LABS, INC terminated Original Note with Leviston Resources, LLC valued at $4 million (effective 2026-05-18).
“On May 18, 2026, the Company satisfied in full the entire $4 million of outstanding principal under the Original Note, together with all accrued interest thereon, through the conversion of such amounts into shares of Common Stock.”
MOBIX LABS, INC amended First Amendment with Leviston Resources, LLC valued at $4 million (effective 2026-05-13).
“On May 13, 2026, Mobix Labs, Inc. (the “Company”) entered into a first amendment to the securities purchase agreement and senior secured convertible promissory note (the “First Amendment”), with Leviston Resources, LLC (“Leviston”), amending the senior secured convertible note originally issued on March 31, 2026 (the “Original Note”) to increase the principal amount from $3 million to $4 million in exchange for an additional cash advance of $833,333 to the Company.”
MOBIX LABS, INC issued common stock.
“On April 2, 2026, Mobix Labs, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which became effective at 4:00 p.m. Eastern Time on April 6, 2026, and implemented a one-for-ten (1:10) reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of Class A Common Stock and Class B Common Stock, each with a par value $0.00001 per share (together, the “Common Stock”).”
MOBIX LABS, INC: Filed Certificate of Amendment to effect a one-for-ten reverse stock split of Common Stock (effective 2026-04-06).
“On April 2, 2026, Mobix Labs, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which became effective at 4:00 p.m. Eastern Time on April 6, 2026, and implemented a one-for-ten (1:10) reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of Class A Common Stock and Class B Common Stock, each with a par value $0.00001 per share (together, the “Common Stock”).”
MOBIX LABS, INC entered into Securities Purchase Agreement, Convertible Note and Registration Rights Agreement with Leviston Resources, LLC valued at Securities Purchase Agreement for senior secured convertible promissory note in original principal a (effective 2026-03-31).
“On March 31, 2026, Mobix Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Leviston Resources, LLC, a Delaware limited liability company (“Leviston”). Pursuant to the Securities Purchase Agreement, Leviston purchased from the Company a senior secured convertible promissory note in the original principal amount of $3,000,000 (the “Convertible Note”) for a purchase price of $2,550,000.”
MOBIX LABS, INC incurred convertible notes of original principal amount of $3,000,000 with Leviston Resources, LLC at annual rate of 10% maturing matures on July 31, 2026.
“On March 31, 2026, Mobix Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Leviston Resources, LLC, a Delaware limited liability company (“Leviston”). Pursuant to the Securities Purchase Agreement, Leviston purchased from the Company a senior secured convertible promissory note in the original principal amount of $3,000,000 (the “Convertible Note”) for a purchase price of $2,550,000.”
MOBIX LABS, INC: Reduced stockholder meeting quorum requirement from majority to one-third of voting power (effective 2026-02-27).
“The amendment of the Bylaws reduces the quorum requirement for all meetings of stockholders (unless otherwise provided by statute, the Company’s amended and restated certificate of incorporation or regulations of any stock exchange applicable to the Company) from the presence, in person or by proxy, of a majority in voting power of the then outstanding shares of stock entitled to vote to the presence, in person or by proxy, of one-third of the voting power of the outstanding shares of stock entitled to vote.”
MOBIX LABS, INC entered into Lock-Up Agreement with Executive officers and directors of Mobix Labs, Inc. valued at 30-day lock-up period on sales or transfers of Company securities by officers and directors (effective 2026-01-06).
“Additionally each of the Company’s executive officers and directors have entered into a lock-up agreement (the “ Lock-Up Agreement ”) pursuant to which each have agreed, subject to certain exceptions set forth therein, not to sell or transfer any of the Company securities which they hold during the 30-day period following the closing date of the Offering.”
MOBIX LABS, INC entered into Placement Agency Agreement with D. Boral Capital LLC valued at Cash placement fee of 8.0% of aggregate gross proceeds; non-accountable expense reimbursement up to (effective 2026-01-06).
“In connection with the Offering, the Company entered into a placement agency agreement (the “ Placement Agency Agreement ”) with D. Boral Capital LLC (the “ Placement Agent ”).”
MOBIX LABS, INC entered into Securities Purchase Agreement with Investors listed on signature pages valued at 30,000,000 shares of Class A common stock at $0.20 per share; net proceeds approximately $5,135,000 (effective 2026-01-06).
“On January 6, 2026, Mobix Labs, Inc., a Delaware corporation (the “ Company ”) entered into certain securities purchase agreements (the “ Purchase Agreements ”) with the investors listed on the signature pages thereto, relating to a public offering of 30,000,000 shares (the “ Shares ”) of the Company’s Class A common stock, par value $0.00001 per share (the “ Common Stock ”), at a price to the public of $0.20 per share (the “ Offering ”).”
MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl”
MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding market value (rules 5550(a)(2), 5550(b)(2)).
“Requirement”). Nasdaq Listing Rule 5550(b)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum market value of listed securities (“MVLS”) of at least $35 million (the “MVLS Requirement”). The Notices stated that, as of their date, the bid price of the Company’s Class A Common Stock, par value $0.00001 per share (“Common Stock”) was below”
MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2)).
“April 28, 2025, Mobix Labs, Inc. (the “Company”) received two delinquency notification letters (the “Notices”) from the Listing Qualifications Staff (the “Staff”) of Nasdaq stating that the Company was not in compliance with the minimum bid price requirement and the market value of listed securities requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum bid price of at least $1.00 per share (the “Minimum Bid Price Requirement”). Nasdaq Listing Rule 5550(b)(2) requires companies”
Philip Sansone was appointed as Interim Chief Executive Officer at MOBIX LABS, INC.
“On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately.”
MOBIX LABS, INC reported fiscal second quarter ended March 31, 2024 results: revenue $1.1 million. Guidance initiated.
“Revenue: Total revenue grew to $1.1 million in the second quarter of 2024”
MOBIX LABS, INC entered into Business Combination Agreement with RaGe Systems, Inc valued at aggregate consideration of $12,000,000 (effective 2024-05-08).
“on May 8, 2024, Mobix Labs, Inc., a Delaware corporation (the “Company” or “Mobix Labs”), entered into a Business Combination Agreement (the “Business Combination Agreement”) with RaGe Systems, Inc, a Delaware corporation (“RaGE Systems”), and Mobix Merger Sub III, LLC, a Delaware limited liability company (“Merger Sub”) to acquire RaGE Systems, a leader in radio frequency joint design and manufacturing services for aggregate consideration of $12,000,000.”
MOBIX LABS, INC entered into Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC valued at up to $100,000,000 (effective 2024-03-18).
“On March 18, 2024, Mobix Labs, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) and a related Registration Rights Agreement (the “ Registration Rights Agreement ”), each dated as of March 18, 2024, with B. Riley Principal Capital II, LLC (“ B. Riley Principal Capital II ”).”
Michael Long was appointed as Class III Director at MOBIX LABS, INC.
“On January 22, 2024, the Board appointed Mr. Michael Long as a Class III director of the Board effective immediately for a term expiring at the 2026 Annual Meeting of Stockholders.”
Jiong Ma resigned as Director at MOBIX LABS, INC.
“Dr. Ma resigned from the Company’s Board of Directors (the “Board”) as a director, effective January 22, 2024.”
MOBIX LABS, INC: Ceased to be a shell company as a result of the Transaction.
“As a result of the Transaction, the Company ceased to be a shell company.”
MOBIX LABS, INC: Adopted new code of business conduct and ethics on Closing Date.
“On the Closing Date, in connection with the Closing, the Board adopted a new code of business conduct and ethics applicable to all of the Company’s directors, employees and contractors.”
MOBIX LABS, INC: Changed fiscal year end from December 31 to September 30 effective Closing Date.
“Effective as of the Closing Date, the Company’s fiscal year end changed from December 31 to September 30.”
MOBIX LABS, INC: Amended and restated certificate of incorporation and bylaws.
“On the Closing Date, the Company amended and restated its certificate of incorporation (as amended and restated, the “Amended and Restated Charter”), which became effective upon filing with the Secretary of State of the State of Delaware on the Closing Date and included the amendments proposed by the above proposals, and adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective immediately prior to the Closing.”
MOBIX LABS, INC underwent a change of control involving Chavant Capital Acquisition Corp. (closed 2023-12-21).
“the registrant consummated the previously announced transactions pursuant to the Business Combination Agreement”
MOBIX LABS, INC entered into Sponsor Letter Agreement with the Sponsor (effective 2023-12-20).
“On December 20, 2023, Chavant also entered into a Sponsor Letter Agreement with the Sponsor (the “Sponsor Letter Agreement”). Pursuant to the Sponsor Letter Agreement, as consideration for the 199,737 shares issued pursuant to the Sponsor PIPE Subscription Agreement, the Sponsor agreed to forgive, effective upon the Closing, approximately $1,997,370 of aggregate outstanding obligations of Chavant owed to the Sponsor”
MOBIX LABS, INC entered into Sponsor Warrant with the Sponsor (effective 2023-12-19).
“In connection with the execution of the Sponsor PIPE Subscription Agreement, Mobix Labs issued to the Sponsor a warrant to purchase 272,454 shares of Mobix Labs Stock at an exercise price of $0.01 per share, exercisable upon the closing of the Sponsor PIPE Subscription Agreement (the “Sponsor Warrant”).”
MOBIX LABS, INC entered into Sponsor PIPE Subscription Agreement with the Sponsor valued at $1,997,370 (effective 2023-12-19).
“On December 19, 2023, Chavant entered into the subscription agreement (the “Sponsor PIPE Subscription Agreement”) with the Sponsor pursuant to which the Sponsor agreed to purchase, in a private placement that closed substantially concurrently with the Closing, 199,737 shares of Class A Common Stock at a price of $10.00 per share for an aggregate purchase price of $1,997,370 paid through the forgiveness of the Forgiven Chavant Obligations”
MOBIX LABS, INC entered into Sage Hill Warrant with Sage Hill Investors, LLC (effective 2023-12-18).
“In connection with the execution of the Sage Hill PIPE Subscription Agreement, Mobix Labs issued to Sage Hill a warrant to purchase 1,500,000 shares of Mobix Labs Stock at an exercise price of $0.01 per share, exercisable upon the closing of the Sage Hill PIPE Subscription Agreement and stockholder approval (the “Sage Hill Warrant”).”
MOBIX LABS, INC entered into Sage Hill PIPE Subscription Agreement with Sage Hill Investors, LLC valued at $15,000,000 (effective 2023-12-18).
“On December 18, 2023, the Company entered into a subscription agreement (the “Sage Hill PIPE Subscription Agreement”) with Sage Hill Investors, LLC (“Sage Hill”), pursuant to which Sage Hill agreed to purchase, in a private placement that closed substantially concurrently with the Closing of the Transaction, 1,500,000 shares of Class A Common Stock in cash at a price of $10.00 per share for an aggregate purchase price of $15,000,000”
MOBIX LABS, INC entered into Sponsor Letter Agreement with the Sponsor valued at forgave approximately $1,997,370 of aggregate outstanding obligations (effective 2023-12-20).
“On December 20, 2023, Chavant also entered into a Sponsor Letter Agreement with the Sponsor (the “Sponsor Letter Agreement”)”
MOBIX LABS, INC entered into Sponsor Warrant with the Sponsor valued at warrant to purchase 272,454 shares of Mobix Labs Stock at an exercise price of $0.01 per share (effective 2023-12-19).
“Mobix Labs issued to the Sponsor a warrant to purchase 272,454 shares of Mobix Labs Stock at an exercise price of $0.01 per share, exercisable upon the closing of the Sponsor PIPE Subscription Agreement (the “Sponsor Warrant”)”
MOBIX LABS, INC entered into Sponsor PIPE Subscription Agreement with the Sponsor valued at 199,737 shares of Class A Common Stock at a price of $10.00 per share for an aggregate purchase pric (effective 2023-12-19).
“On December 19, 2023, Chavant entered into the subscription agreement (the “Sponsor PIPE Subscription Agreement”) with the Sponsor”
MOBIX LABS, INC entered into "Sage Hill PIPE Subscription Agreement" with Sage Hill Investors, LLC valued at $15,000,000 (effective 2023-12-18).
“As of December 18, 2023, Chavant entered into a subscription agreement with Sage Hill Investors, LLC (“Sage Hill”) and Mobix Labs (the “Sage Hill PIPE Subscription Agreement”) pursuant to which Sage Hill has agreed to purchase, in a private placement to close substantially concurrently with the Closing of the Proposed Transaction, 1,500,000 shares of Class A Common Stock in cash at a price of $10.00 per share for an aggregate purchase price of $15,000,000”
MOBIX LABS, INC shareholders approved Director Election Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Director Election Proposal: For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Employee Stock Purchase Plan Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Employee Stock Purchase Plan Proposal: For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Equity Incentive Plan Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Equity Incentive Plan Proposal: For Against Abstain Broker Non-Votes 2,490,389 9,023 0 N/A”
MOBIX LABS, INC shareholders approved Nasdaq Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Nasdaq Proposal: For Against Abstain Broker Non-Votes 2,490,390 9,022 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Change of Corporate Name) at the 2023-12-18 meeting.
“(k) Change of Corporate Name For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Choice of Forum) at the 2023-12-18 meeting.
“(j) Choice of Forum For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Remove Renouncement of Corporate Opportunities) at the 2023-12-18 meeting.
“(i) Remove Renouncement of Corporate Opportunities For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Eliminate the Ability of the Holders of Class A Common Stock to Act by Written Consent) at the 2023-12-18 meeting.
“(h) Eliminate the Ability of the Holders of Class A Common Stock to Act by Written Consent For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Amendment of Bylaws) at the 2023-12-18 meeting.
“(g) Amendment of Bylaws For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Amendment of Charter) at the 2023-12-18 meeting.
“(f) Amendment of Charter For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Removal of Directors) at the 2023-12-18 meeting.
“(e) Removal of Directors For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Right of the Holders of Class B Common Stock to Elect Certain Directors) at the 2023-12-18 meeting.
“(d) Right of the Holders of Class B Common Stock to Elect Certain Directors For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Voting Rights of Common Stock) at the 2023-12-18 meeting.
“(c) Voting Rights of Common Stock For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Authorized Capital Stock) at the 2023-12-18 meeting.
“(b) Authorized Capital Stock For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Advisory Governance Proposals (Removal of Special Purpose Acquisition Company Provisions) at the 2023-12-18 meeting.
“Advisory Governance Proposals: (a) Removal of Special Purpose Acquisition Company Provisions For Against Abstain Broker Non-Votes 2,496,407 3,005 0 N/A”
MOBIX LABS, INC shareholders approved Organizational Documents Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Organizational Documents Proposal: For Against Abstain Broker Non-Votes 2,496,408 3,004 0 N/A”
MOBIX LABS, INC shareholders approved Domestication Proposal at the 2023-12-18 meeting.
“Set forth below are the voting results for the Domestication Proposal: For Against Abstain Broker Non-Votes 2,496,357 3,005 50 N/A”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.